DNA damage repair gene signature model for predicting prognosis and chemotherapy outcomes in lung squamous cell carcinoma

BACKGROUND: Lung squamous cell carcinoma (LUSC) is prone to metastasis and likely to develop resistance to chemotherapeutic drugs. DNA repair has been reported to be involved in the progression and chemoresistance of LUSC. However, the relationship between LUSC patient prognosis and DNA damage repai...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Xinshu, Huang, Zhiyuan, Li, Lei, Wang, Guangxue, Dong, Lin, Li, Qinchuan, Yuan, Jian, Li, Yunhui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9361681/
https://www.ncbi.nlm.nih.gov/pubmed/35941578
http://dx.doi.org/10.1186/s12885-022-09954-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9361681/
https://www.ncbi.nlm.nih.gov/pubmed/35941578
http://dx.doi.org/10.1186/s12885-022-09954-x

Ejemplares similares